Safety and Efficacy of Ivabradine Hydrochloride in Hemodialysis Patients with Chronic Heart Failure - Safety and Efficacy of Ivabradine Hydrochloride in Hemodialysis Patients with Chronic Heart Failure

ippon Medical School0 个研究点目标入组 50 人开始时间: 2021年10月26日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. patients with a history of hypersensitivity to any component of ivabradine hydrochloride 2. patients with unstable or acute heart failure 3. patients with cardiogenic shock 4. patients with severe hypotension (systolic blood pressure less than 90 mmHg or diastolic blood pressure less than 50 mmHg) 5. patients with atrial fibrillation 6. patients with sinus failure syndrome, sinoatrial block, or third degree atrioventricular block 7. patients with severe hepatic dysfunction 7) Patients with severe hepatic dysfunction (Child-Pugh C) 8. patients receiving the following drugs: ritonavir-containing products, josamycin, itraconazole, clarithromycin, cobicistat-containing products, indinavir, voriconazole, nelfinavir, saquinavir, telaprevir 9. patients who are pregnant, lactating, may be pregnant or plan to become pregnant 10. patients who are receiving verapamil or diltiazem 11. patients who are scheduled to undergo surgical treatment during the study period 12. 12. patients who require a substitute.

发起方

ippon Medical School